Trial Profile
Efficacy of Bortezomib in Kidney transplant patients with antibody mediated rejection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Oct 2016
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Rituximab
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 13 Oct 2016 New trial record